JP2003519164A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003519164A5 JP2003519164A5 JP2001549618A JP2001549618A JP2003519164A5 JP 2003519164 A5 JP2003519164 A5 JP 2003519164A5 JP 2001549618 A JP2001549618 A JP 2001549618A JP 2001549618 A JP2001549618 A JP 2001549618A JP 2003519164 A5 JP2003519164 A5 JP 2003519164A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- release
- polymer
- formulation
- dth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 13
- 229920000642 polymer Polymers 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 9
- 230000000975 bioactive effect Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920001230 polyarylate Polymers 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 230000009477 glass transition Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 230000003111 delayed effect Effects 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 235000011037 adipic acid Nutrition 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 125000003262 carboxylic acid ester group Chemical group [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RZICEOJUAFHYFO-UHFFFAOYSA-N 1-hydroperoxyhexane Chemical compound CCCCCCOO RZICEOJUAFHYFO-UHFFFAOYSA-N 0.000 description 1
- 229940124718 AIDS vaccine Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17413799P | 1999-12-31 | 1999-12-31 | |
| US60/174,137 | 1999-12-31 | ||
| PCT/US2001/000030 WO2001049249A2 (en) | 1999-12-31 | 2001-01-02 | Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003519164A JP2003519164A (ja) | 2003-06-17 |
| JP2003519164A5 true JP2003519164A5 (cg-RX-API-DMAC7.html) | 2011-04-28 |
Family
ID=22634986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001549618A Pending JP2003519164A (ja) | 1999-12-31 | 2001-01-02 | ポリマーマトリクスに基づく生理活性化合物徐放調節用医薬製剤 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1263453A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003519164A (cg-RX-API-DMAC7.html) |
| AU (1) | AU784226B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2396037A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001049249A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1251864A4 (en) * | 1999-12-31 | 2006-02-22 | Univ Rutgers | PHARMACEUTICAL FORMULATION COMPRISING A POLYMERIC MIXTURE AND AN ACTIVE COMPOUND FOR TIME-RELEASED RELEASE |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| ES2383525T3 (es) | 2003-11-05 | 2012-06-21 | Sarcode Bioscience Inc. | Moduladores de la adhesión celular |
| JP5794721B2 (ja) | 2005-05-17 | 2015-10-14 | サーコード バイオサイエンス インコーポレイテッド | 眼障害の治療のための組成物および方法 |
| US8636753B2 (en) | 2006-02-08 | 2014-01-28 | Tyrx, Inc. | Temporarily stiffened mesh prostheses |
| US8315700B2 (en) | 2006-02-08 | 2012-11-20 | Tyrx, Inc. | Preventing biofilm formation on implantable medical devices |
| US9265865B2 (en) | 2006-06-30 | 2016-02-23 | Boston Scientific Scimed, Inc. | Stent having time-release indicator |
| US9023114B2 (en) | 2006-11-06 | 2015-05-05 | Tyrx, Inc. | Resorbable pouches for implantable medical devices |
| EP2079387B1 (en) | 2006-11-06 | 2017-04-12 | Tyrx, Inc. | Mesh pouches for implantable medical devices |
| MX2009010396A (es) | 2007-03-29 | 2009-12-02 | Tyrx Pharma Inc | Cubiertas polimericas biodegradables para implantes de mama. |
| JP5581202B2 (ja) | 2007-05-02 | 2014-08-27 | タイレックス・インコーポレイテッド | ジヒドロキシベンゾエートポリマーおよびその使用 |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| ES2559319T3 (es) | 2007-06-04 | 2016-02-11 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato cliclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| US8034782B2 (en) | 2008-07-16 | 2011-10-11 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2630406T3 (es) | 2007-10-19 | 2017-08-21 | Sarcode Bioscience Inc. | Composición y procedimientos para el tratamiento de la retinopatía diabética |
| US8080562B2 (en) | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| EP2328910B1 (en) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8652525B2 (en) | 2008-07-10 | 2014-02-18 | Tyrx, Inc. | NSAID delivery from polyarylates |
| CA2737769C (en) | 2008-09-22 | 2014-02-04 | Arthur Schwartz | Linear polyesteramides from aminophenolic esters |
| US9839628B2 (en) | 2009-06-01 | 2017-12-12 | Tyrx, Inc. | Compositions and methods for preventing sternal wound infections |
| EP2437724B1 (en) * | 2009-06-01 | 2015-09-30 | Tyrx, Inc. | Compositions and methods for preventing sternal wound infections |
| EP2459638B1 (en) * | 2009-07-31 | 2017-09-27 | Rutgers, The State University of New Jersey | Monomers and phase-separated biocompatible polymer compositions prepared therefrom for medical uses |
| US8409279B2 (en) | 2009-10-01 | 2013-04-02 | Lipose Corporation | Breast implant implantation method and apparatus |
| WO2011050175A1 (en) | 2009-10-21 | 2011-04-28 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
| AU2011293344B2 (en) | 2010-08-25 | 2015-07-30 | Medtronic, Inc. | Novel medical device coatings |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| JP6397190B2 (ja) | 2010-11-12 | 2018-09-26 | タイレックス・インコーポレイテッドＴｙｒｘ Ｉｎｃ． | 有効医薬品成分を含む固着装置 |
| AU2012283875B2 (en) | 2011-07-20 | 2016-05-12 | Medtronic, Inc. | Drug eluting mesh to prevent infection of indwelling transdermal devices |
| SI3715345T1 (sl) | 2012-07-25 | 2024-07-31 | Bausch + Lomb Ireland Limited | Priprava zaviralca lfa-1 |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| WO2014137454A1 (en) | 2013-03-07 | 2014-09-12 | Tyrx, Inc. | Methods and compositions to inhibit the assemblage of microbial cells irreversibly associated with surfaces of medical devices |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| AU2014235215A1 (en) | 2013-03-15 | 2015-10-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| US20160220630A1 (en) | 2013-10-10 | 2016-08-04 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions |
| WO2015069305A1 (en) | 2013-11-08 | 2015-05-14 | Tyrx, Inc. | Antimicrobial compositions and methods for preventing infection in surgical incision sites |
| US20170231916A1 (en) * | 2014-08-04 | 2017-08-17 | Janssen Sciences Ireland Uc | Compacted solid dosage form |
| EP3402804A1 (en) | 2016-01-11 | 2018-11-21 | Synergy Pharmaceuticals Inc. | Formulations and methods for treating ulcerative colitis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5587507A (en) * | 1995-03-31 | 1996-12-24 | Rutgers, The State University | Synthesis of tyrosine derived diphenol monomers |
| US5658995A (en) * | 1995-11-27 | 1997-08-19 | Rutgers, The State University | Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide) |
| US6120491A (en) * | 1997-11-07 | 2000-09-19 | The State University Rutgers | Biodegradable, anionic polymers derived from the amino acid L-tyrosine |
| CA2281614C (en) * | 1997-02-18 | 2008-11-18 | Rutgers, The State University Of New Jersey | Monomers derived from hydroxy acids and polymers prepared therefrom |
| DE19719817A1 (de) * | 1997-05-13 | 1998-11-19 | Hoechst Ag | Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren |
| ZA9811377B (en) * | 1997-12-12 | 1999-08-27 | Expression Genetics Inc | Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid[ for the delivery of a bioactive agent via tissue and cellular uptake. |
| AU761458B2 (en) * | 1998-04-13 | 2003-06-05 | Rutgers, The State University | The construction of copolymer libraries |
| AU2373200A (en) * | 1999-02-05 | 2000-08-25 | Alien Technology Corporation | Apparatuses and methods for forming assemblies |
-
2001
- 2001-01-02 AU AU29255/01A patent/AU784226B2/en not_active Expired
- 2001-01-02 WO PCT/US2001/000030 patent/WO2001049249A2/en not_active Ceased
- 2001-01-02 EP EP01939971A patent/EP1263453A4/en not_active Ceased
- 2001-01-02 JP JP2001549618A patent/JP2003519164A/ja active Pending
- 2001-01-02 CA CA002396037A patent/CA2396037A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003519164A5 (cg-RX-API-DMAC7.html) | ||
| EP0952171B1 (en) | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof | |
| US4942035A (en) | Continuous release formulations | |
| TWI250028B (en) | Biodegradable ph/thermosensitive hydrogel for sustained delivery of biologically active agents | |
| US5529777A (en) | Hydrogel microencapsulated vaccines | |
| JP2963540B2 (ja) | 薬剤移送用ポリマーミクロ粒子 | |
| US4863735A (en) | Biodegradable polymeric drug delivery system with adjuvant activity | |
| Petrovsky et al. | Vaccine adjuvants: current state and future trends | |
| CN1205248C (zh) | 能溶解在有机溶剂中的生物可降解的聚环氧烷－聚(对－二噁烷酮)嵌段共聚物及含该共聚物的药物供送组合物 | |
| US4882168A (en) | Polyesters containing alkylene oxide blocks as drug delivery systems | |
| Kissel et al. | Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly (lactide-co-glycolide) A blocks and hydrophilic poly (ethylene oxide) B blocks | |
| CA1288344C (en) | Drug delivery system | |
| Zhou et al. | Poly-d, l-lactide–co-poly (ethylene glycol) microspheres as potential vaccine delivery systems | |
| EP2316490A3 (en) | Methods and compositions for enhanced delivery of bioactive molecules | |
| JP2007308500A (ja) | Ｇｍ−ｃｓｆの放出の延長 | |
| CA2203857A1 (en) | Microparticles for delivery of nucleic acid | |
| PT863933E (pt) | Novos hidrogeis a base de copolimeros de bloco com res sequencias sua preparacao e sua aplicacao | |
| CA2167081A1 (en) | Hydrogel microencapsulated vaccines | |
| CA2424936A1 (en) | Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight | |
| WO1995002416A9 (en) | Hydrogel microencapsulated vaccines | |
| Ghahremankhani et al. | PLGA-PEG-PLGA tri-block copolymers as an in-situ gel forming system for calcitonin delivery | |
| CN1446833A (zh) | 一种温敏性可降解微凝胶及其制备方法 | |
| EP2421505A2 (en) | Hydrogels for combinatorial delivery of immune-modulating biomolecules | |
| US20060233857A1 (en) | Degradable elastomeric network | |
| CN118320058A (zh) | 具有选定的释放持续时间的药物组合物 |